References: Seiwerth, S., Milavi, M., Vukojevi, J., Gojkovi, S., Krezic, I., Batelja Vuleti, L., Horvat Pavlov, K., Petrovic, A., Sikiric, S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Knezevic, M., Sola, M., Kokot, A., Sever, M., Lovric, E., Skrtic, A., Boban Blagaic, A., & Sikiric, P
Introduction The field of regenerative medicine has experienced considerable advancement with the development of peptide-based therapeutics targeting tissue repair and homeostatic maintenance
Never stop your diabetic medication without a physicians advice
NNMT (nicotinamide N-methyltransferase) catalyses the methylation of nicotinamide using S-adenosylmethionine (SAM) as the methyl donor, producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine
5-Amino-1MQ remains firmly in the research category, with no clear timeline for any UK approval